Jeffrey Lieberman
Jeffrey Lieberman
Jeffrey Alan Liebermanis an American psychiatrist who specializes in schizophrenia and related psychoses and their associated neuroscienceand drugs. He was principal investigator for CATIE, the largest and longest independent study ever funded by the United States National Institute of Mental Health to examine existing therapies for schizophrenia. He was past president of the American Psychiatric Association from May 2013 to May 2014...
normal observed outside range seen themselves variation
The differences observed are not in and of themselves outside the range of variation seen in the normal population.
biggest effect effects good greater medication older produced rates side surprise three
Probably the biggest surprise of all was that the older medication produced about as good an effect as the newer medications, three of them anyway, and did not produce neurological side effects at greater rates than any of the other drugs,
complete doctors enable experience looking majority medicines patients study symptoms
The study demonstrated that these medicines are effective, but that doctors and patients are looking for more. The medicines didn't completely alleviate symptoms or enable the majority of the patients to experience a complete recovery.
doubt glass half treatments
These treatments are effective--there's no doubt about that. But the glass is only half full.
chronic glass patients treatment
When it comes to the treatment of patients with chronic schizophrenia, the glass is only half-full.